Company Encyclopedia
View More
name
BUCHANG PHARMA
603858.SH
Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.
3.144 T
603858.SHMarket value -Rank by Market Cap -/-

Financial Score

09/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking92/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE0.02%D
    • Profit Margin0.02%D
    • Gross Margin62.07%A
  • Growth ScoreD
    • Revenue YoY-6.93%D
    • Net Profit YoY100.57%A
    • Total Assets YoY-2.87%D
    • Net Assets YoY-6.77%D
  • Cash ScoreB
    • Cash Flow Margin659213.96%A
    • OCF YoY-6.93%D
  • Operating ScoreC
    • Turnover0.55C
  • Debt ScoreC
    • Gearing Ratio48.53%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Buchang Pharma Modifies Shaanxi Drug Manufacturing License

    Buchang Pharma Modifies Shaanxi Drug Manufacturing License

    marketscreener·
    SH
    603858
    -1.72%
    marketscreener·
    SH
    603858
    -1.72%

    Buchang Pharma Signs Contract for Clinical Trial of Traditional Chinese Drug

    Buchang Pharma Signs Contract for Clinical Trial of Traditional Chinese Drug

    marketscreener·
    SH
    603858
    -1.72%
    marketscreener·
    SH
    603858
    -1.72%

    Buchang Pharma Gets Regulatory Approval for Drug Manufacturing License Changes

    Buchang Pharma Gets Regulatory Approval for Drug Manufacturing License Changes

    marketscreener·
    SH
    603858
    -1.72%
    marketscreener·
    SH
    603858
    -1.72%

    Buchang Pharma Transfers Key Drug Clinical Development to Subsidiary

    Buchang Pharma Transfers Key Drug Clinical Development to Subsidiary

    marketscreener·
    SH
    603858
    -1.72%
    marketscreener·
    SH
    603858
    -1.72%

    BUCHANG PHARMA: Director Zhao Chao resigns for personal reasons

    BUCHANG PHARMA announced that the company's director Zhao Chao resigned on October 17, 2025, for personal reasons, with the original term set to end on June 28, 2027. After resigning, Zhao Chao will continue to serve as president and does not hold any shares in the company. The company will complete the election of a new director as soon as possible. The company expresses its gratitude for Zhao Chao's contributions during his tenure

    Zhitong·
    SH
    603858
    -1.72%
    Zhitong·
    SH
    603858
    -1.72%
    © 2025 Longbridge｜Disclaimer